RA CAPITAL MANAGEMENT, L.P.
Q1 2024 13F-HR Holdings
Net value change ($000)
+1,396,296
(21.8%)
New positions
20
Sold out positions
7
Turnover %
25.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ASND | 255,060 | 20.0% |
| JANX | 246,740 | 250.9% |
| EWTX | 162,502 | NEW |
| DYN | 140,666 | NEW |
| EVH | 103,890 | 123.4% |
| PEPG | 101,839 | 184.2% |
| NAMS | 98,143 | 111.7% |
| LENZ | 93,313 | NEW |
| FDMT | 76,594 | 90.8% |
| APGE | 76,169 | 137.8% |
Top Reduces (Value $000, Stocks/ETFs)
| ImmunoGen, Inc. | -704,205 | -100.0% |
| CymaBay Therapeutics, Inc. | -163,923 | -100.0% |
| ANTX | -95,704 | -84.1% |
| Icosavax, Inc. | -93,986 | -100.0% |
| ALPINE IMMUNE SCIENCES, INC. | -93,580 | -100.0% |
| Inhibrx, Inc. | -87,581 | -48.8% |
| VRNA | -23,946 | -19.1% |
| Harpoon Therapeutics, Inc. | -17,055 | -100.0% |
| CTKB | -16,411 | -26.4% |
| RYTM | -14,072 | -5.7% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|